Citations for
1ALSFTD1, C9orf72
The shared ancestry between the C9orf72 hexanucleotide repeat expansion and intermediate-length alleles using haplotype sharing trees and HAPTK.
Rautila OS, Kaivola K, Rautila H, Hokkanen L, Launes J, Strandberg TE, Laaksovirta H, Palmio J, Tienari PJ.
Am J Hum Genet. Feb 1;111(2):383-392. doi: 10.1016/j.ajhg.2023.12.019. Epub 2024 Jan 18. 2024
2C9orf72, SMCR8
The C9orf72-SMCR8 complex suppresses primary ciliogenesis as a RAB8A GAP.
Tang D, Bao H, Qi S.
Autophagy. Jan 31:1-3. doi: 10.1080/15548627.2024.2311541. Epub ahead of print. 2024
3C9ORF72, DAXX
DNA-initiated epigenetic cascades driven by C9orf72 hexanucleotide repeat.
Liu Y, Huang Z, Liu H, Ji Z, Arora A, Cai D, Wang H, Liu M, Simko EAJ, Zhang Y, Periz G, Liu Z, Wang J.
Neuron. Apr 19;111(8):1205-1221.e9. doi: 10.1016/j.neuron.2023.01.022. Epub 2023 Feb 22. Erratum in: Neuron. 2023 Apr 19;111(8):1345 2023
4C9orf72, SMCR8
C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.
Jülg J, Edbauer D, Behrends C
EMBO Rep. Aug 3;24(8):e55895. doi: 10.15252/embr.202255895. Epub 2023 Jun 15. 2023
5C9orf72
C9orf72 functions in the nucleus to regulate DNA damage repair.
He L, Liang J, Chen C, Chen J, Shen Y, Sun S, Li L.
Cell Death Differ. Mar;30(3):716-730. doi: 10.1038/s41418-022-01074-0. Epub 2022 Oct 11 2023
6C9orf72, SMCR8, WDR41
Pathogenesis underlying hexanucleotide repeat expansions in C9orf72 gene in amyotrophic lateral sclerosis
Chong ZZ, Menkes DL, Souayah N.
Rev Neurosci. Aug 2;35(1):85-97. doi: 10.1515/revneuro-2023-0060 2023
7C9orf72, SMCR8, WDR41
The progress in C9orf72 research: ALS/FTD pathogenesis, functions and structure
Jiang L, Zhang T, Lu K, Qi S.
Small GTPases Jan;13(1):56-76. doi: 10.1080/21541248.2021.1892443. Epub 2021 Mar 5. 2022
8C9ORF72, TIMMDC1
C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly.
Wang T, Liu H, Itoh K, Oh S, Zhao L, Murata D, Sesaki H, Hartung T, Na CH, Wang J
Cell Metab. Mar 2;33(3):531-546.e9. doi: 10.1016/j.cmet.2021.01.005. Epub 2021 Feb 4. 2021
9C9orf72
C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation.
Lall D, Lorenzini I, Mota TA, Bell S, Mahan TE, Ulrich JD, Davtyan H, Rexach JE, Muhammad AKMG, Shelest O, Landeros J, Vazquez M, Kim J, Ghaffari L, O'Rourke JG, Geschwind DH, Blurton-Jones M, Holtzman DM, Sattler R, Baloh RH.
Neuron Jul 21;109(14):2275-2291.e8. doi: 10.1016/j.neuron.2021.05.020. Epub 2021 Jun 15 2021
10C9orf72
Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Ghasemi M, Keyhanian K, Douthwright C.
Cells. Jan 28;10(2):249. doi: 10.3390/cells10020249. 2021
11C9orf72, STING1
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD.
Pang W, Hu F.
J Neurochem. May;157(3):334-350. doi: 10.1111/jnc.15255. Epub 2020 Dec 18 2021
12C9orf72, SMCR8, WDR41
Structure of the human C9orf72-SMCR8 complex reveals a multivalent protein interaction architecture.
Nörpel J, Cavadini S, Schenk AD, Graff-Meyer A, Hess D, Seebacher J, Chao JA, Bhaskar V.
PLoS Biol. Jul 23;19(7):e3001344. doi: 10.1371/journal.pbio.3001344 2021
13C9orf72, SMCR8, WDR41
The C9orf72-SMCR8-WDR41 complex is a GAP for small GTPases
Tang D, Sheng J, Xu L, Yan C, Qi S.
Autophagy. Aug;16(8):1542-1543. doi: 10.1080/15548627.2020.1779473. Epub 2020 Jun 17 2020
14C9orf72, PQLC2, WDR41
PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation.
Amick J, Tharkeshwar AK, Talaia G, Ferguson SM.
J Cell Biol. Jan 6;219(1):e201906076. doi: 10.1083/jcb.201906076. 2020
15C9orf72, SMCR8, WDR41
Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD
Su MY, Fromm SA, Zoncu R, Hurley JH.
Nature. Sep;585(7824):251-255. doi: 10.1038/s41586-020-2633-x. Epub 2020 Aug 26. 2020
16C9orf72, MTOR, SMCR8
SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis
Lan Y, Sullivan PM, Hu F.
Autophagy. May;15(5):871-885. doi: 10.1080/15548627.2019.1569914. Epub 2019 Jan 29 2019
17ALSFTD1, C9orf72
Disease Mechanisms of C9ORF72 Repeat Expansions.
Gendron TF, Petrucelli L.
Cold Spring Harb Perspect Med. Apr 2;8(4):a024224. doi: 10.1101/cshperspect.a024224. 2018
18C9orf72, SMCR8, WDR41
WDR41 supports lysosomal response to changes in amino acid availability.
Amick J, Tharkeshwar AK, Amaya C, Ferguson SM.
Mol Biol Cell. Sep 1;29(18):2213-2227. doi: 10.1091/mbc.E17-12-0703. Epub 2018 Jul 11. 2018
19C9orf72, SMCR8
The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis.
Zhang Y, Burberry A, Wang JY, Sandoe J, Ghosh S, Udeshi ND, Svinkina T, Mordes DA, Mok J, Charlton M, Li QZ, Carr SA, Eggan K.
Genes Dev. Jul 1;32(13-14):929-943. doi: 10.1101/gad.313932.118. Epub 2018 Jun 27. 2018
20C9ORF72, RAB29
C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AG, Varela MA, Sathyaprakash C, Scaber J, Barbagallo P, Vader P, Mäger I, Ezzat K, Turner MR, Ito N, Gasco S, Ohbayashi N, El Andaloussi S, Takeda S, Fukuda M, Talbot K, Wood MJ.
Brain rain. 2017 Feb 23. doi: 10.1093/brain/awx024. [Epub ahead of print] 2017
21C9ORF72
C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease.
Amick J, Ferguson SM.
Traffic raffic. 2017 Mar 7. doi: 10.1111/tra.12477. [Epub ahead of print] Review. 2017
22C9ORF72
Loss of C9orf72 function leads to autoimmunity.
Sakkas LI, Bogdanos DP, Kousvelari EE.
Ann Transl Med 5(3):60. doi: 10.21037/atm.2017.01.33. No abstract available. 2017
23C9orf72, SMCR8, WDR41
C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease.
Amick J, Ferguson SM.
Traffic May;18(5):267-276. doi: 10.1111/tra.12477. Epub 2017 Mar 23. 2017
24C9ORF72
C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers.
Rizzu P, Blauwendraat C, Heetveld S, Lynes EM, Castillo-Lizardo M, Dhingra A, Pyz E, Hobert M, Synofzik M, Simón-Sánchez J, Francescatto M, Heutink P.
Acta Neuropathol Commun 4(1):37. doi: 10.1186/s40478-016-0306-7. 2016
25C9ORF72
C9orf72 is required for proper macrophage and microglial function in mice.
O'Rourke JG, Bogdanik L, Yáńez A, Lall D, Wolf AJ, Muhammad AK, Ho R, Carmona S, Vit JP, Zarrow J, Kim KJ, Bell S, Harms MB, Miller TM, Dangler CA, Underhill DM, Goodridge HS, Lutz CM, Baloh RH.
Science 351(6279):1324-9. doi: 10.1126/science.aaf1064. 2016
26ALSFTD1, C9orf72
Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.
Niblock M, Smith BN, Lee YB, Sardone V, Topp S, Troakes C, Al-Sarraj S, Leblond CS, Dion PA, Rouleau GA, Shaw CE, Gallo JM.
Acta Neuropathol Commun 4:18. doi: 10.1186/s40478-016-0289-4. 2016
27C9orf72, RAB1A
The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy
Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, Myszczynska MA, Higginbottom A, Walsh MJ, Whitworth AJ, Kaspar BK, Meyer K, Shaw PJ, Grierson AJ, De Vos KJ.
EMBO J. Aug 1;35(15):1656-76. doi: 10.15252/embj.201694401. Epub 2016 Jun 22. 2016
28C9orf72, SMCR8
A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy.
Yang M, Liang C, Swaminathan K, Herrlinger S, Lai F, Shiekhattar R, Chen JF.
Sci Adv. Sep 2;2(9):e1601167. doi: 10.1126/sciadv.1601167 2016
29ALSFTD1, C9orf72
Jump from Pre-mutation to Pathologic Expansion in C9orf72.
Xi Z, van Blitterswijk M, Zhang M, McGoldrick P, McLean JR, Yunusova Y, Knock E, Moreno D, Sato C, McKeever PM, Schneider R, Keith J, Petrescu N, Fraser P, Tartaglia MC, Baker MC, Graff-Radford NR, Boylan KB, Dickson DW, Mackenzie IR, Rademakers R, Robertson J, Zinman L, Rogaeva E.
Am J Hum Genet 96(6):962-70. doi: 10.1016/j.ajhg.2015.04.016. Epub 2015 May 21. 2015
30C9ORF72
Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers.
Walhout R, Schmidt R, Westeneng HJ, Verstraete E, Seelen M, van Rheenen W, de Reus MA, van Es MA, Hendrikse J, Veldink JH, van den Heuvel MP, van den Berg LH.
Neurology 85(20):1780-8. doi: 10.1212/WNL.0000000000002135. Epub 2015 Oct 23. 2015
31C9ORF72
Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers.
Walhout R, Schmidt R, Westeneng HJ, Verstraete E, Seelen M, van Rheenen W, de Reus MA, van Es MA, Hendrikse J, Veldink JH, van den Heuvel MP, van den Berg LH.
Neurology 85(20):1780-8. doi: 10.1212/WNL.0000000000002135. Epub 2015 Oct 23. 2015
32C9orf72
The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, Gupta S, Thomas MA, Hong I, Chiu SL, Huganir RL, Ostrow LW, Matunis MJ, Wang J, Sattler R, Lloyd TE, Rothstein JD.
Nature 525(7567):56-61. doi: 10.1038/nature14973. Epub 2015 Aug 26. 2015
33ALYREF, C9ORF72
Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy
Cooper-Knock J, Higginbottom A, Stopford MJ, Highley JR, Ince PG, Wharton SB, Pickering-Brown S, Kirby J, Hautbergue GM, Shaw PJ.
Acta Neuropathol. Jul;130(1):63-75. doi: 10.1007/s00401-015-1429-9. Epub 2015 May 6. 2015
34C9ORF72
C9orf72 repeat expansions in rapid eye movement sleep behaviour disorder.
Daoud H, Postuma RB, Bourassa CV, Rochefort D, Gauthier MT, Montplaisir J, Gagnon JF, Arnulf I, Dauvilliers Y, Charley CM, Inoue Y, Sasai T, Högl B, Desautels A, Frauscher B, Cochen De Cock V, Rouleau GA, Dion PA.
Can J Neurol Sci 41(6):759-62. doi: 10.1017/cjn.2014.39. Epub 2014 Nov 4. 2014
35ALSFTD1, ATXN2, C9orf72
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.
van Blitterswijk M, Mullen B, Heckman MG, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White CL 3rd, Neumann M, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R.
Neurobiol Aging 35(10):2421.e13-7. doi: 10.1016/j.neurobiolaging.2014.04.016. Epub 2014 May 2. 2014
36C9orf72
Large C9orf72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK Population.
Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S.
Am J Hum Genet 92(3):345-53. doi: 10.1016/j.ajhg.2013.01.011. Epub 2013 Feb 21. 2013
37C9orf72
Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation.
Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, Fumagalli GG, Del Bo R, Bruni AC, Anfossi M, Clodomiro A, Cupidi C, Nacmias B, Sorbi S, Piaceri I, Bagnoli S, Bessi V, Marcone A, Cerami C, Cappa SF, Filippi M, Agosta F, Magnani G, Comi G, Franceschi M, Rainero I, Giordana M, Rubino E, Ferrero P, Rogaeva E, Xi Z, Confaloni A, Piscopo P, Bruno G, Talarico G, Cagnin A, Clerici F, Dell' Osso B, Comi GP, Altamura AC, Mariani C, Scarpini E.
Biol Psychiatry iol Psychiatry. 2013 Mar 7. doi:pii: S0006-3223(13)00130-3. 10.1016/j.biopsych.2013.01.031. [Epub ahead of print] 2013
38C9orf72
Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion.
Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, Zheng Y, Ghani M, Dib S, Keith J, Robertson J, Rogaeva E.
Am J Hum Genet m J Hum Genet. 2013 May 22. doi:pii: S0002-9297(13)00178-X. 10.1016/j.ajhg.2013.04.017. [Epub ahead of print] 2013
39C9orf72
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.
Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, Miller J, Lee Y, Troakes C, Scott KM, Jones A, Gray I, Wright J, Hortobágyi T, Al-Sarraj S, Rogelj B, Powell J, Lupton M, Lovestone S, Sapp PC, Weber M, Nestor PJ, Schelhaas HJ, Asbroek AA, Silani V, Gellera C, Taroni F, Ticozzi N, Van den Berg L, Veldink J, Van Damme P, Robberecht W, Shaw PJ, Kirby J, Pall H, Morrison KE, Morris A, de Belleroche J, Vianney de Jong JM, Baas F, Andersen PM, Landers J, Brown RH Jr, Weale ME, Al-Chalabi A, Shaw CE.
Eur J Hum Genet 21(1):102-8. doi: 10.1038/ejhg.2012.98. Epub 2012 Jun 13. 2013
40ALSFTD1, C9orf72
Genetic analysis of SIGMAR1 as a cause of familial ALS with dementia.
Belzil VV, Daoud H, Camu W, Strong MJ, Dion PA, Rouleau GA.
Eur J Hum Genet 21(2):237-9. doi: 10.1038/ejhg.2012.135. Epub 2012 Jun 27. 2013
41C9orf72, FTDP17, FTDU17, GRN, MAPT
Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, Rutherford NJ, Baker M, Knopman DS, Wszolek ZK, Parisi JE, Dickson DW, Petersen RC, Rademakers R, Jack CR Jr, Josephs KA.
Brain 135(Pt 3):794-806. doi: 10.1093/brain/aws001. 2012
42C9orf72
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.
Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD.
Brain 135(Pt 3):736-50. doi: 10.1093/brain/awr361. 2012
43C9orf72
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.
Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chiň A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten JC, Abramzon Y, Johnson JO, Sendtner M, Pamphlett R, Orrell RW, Mead S, Sidle KC, Houlden H, Rohrer JD, Morrison KE, Pall H, Talbot K, Ansorge O; Chromosome 9-ALS/FTD Consortium; French research network on FTLD/FTLD/ALS; ITALSGEN Consortium, Hernandez DG, Arepalli S, Sabatelli M, Mora G, Corbo M, Giannini F, Calvo A, Englund E, Borghero G, Floris GL, Remes AM, Laaksovirta H, McCluskey L, Trojanowski JQ, Van Deerlin VM, Schellenberg GD, Nalls MA, Drory VE, Lu CS, Yeh TH, Ishiura H, Takahashi Y, Tsuji S, Le Ber I, Brice A, Drepper C, Williams N, Kirby J, Shaw P, Hardy J, Tienari PJ, Heutink P, Morris HR, Pickering-Brown S, Traynor BJ.
Lancet Neurol 11(4):323-30. doi: 10.1016/S1474-4422(12)70043-1. Epub 2012 Mar 9. 2012
44C9orf72
Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, Baxter L, Forster G, Fox M, Bury J, Mok K, McDermott CJ, Traynor BJ, Kirby J, Wharton SB, Ince PG, Hardy J, Shaw PJ.
Brain 135(Pt 3):751-64. doi: 10.1093/brain/awr365. 2012
45C9orf72
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases.
van Rheenen W, van Blitterswijk M, Huisman MH, Vlam L, van Doormaal PT, Seelen M, Medic J, Dooijes D, de Visser M, van der Kooi AJ, Raaphorst J, Schelhaas HJ, van der Pol WL, Veldink JH, van den Berg LH.
Neurology 79(9):878-82. doi: 10.1212/WNL.0b013e3182661d14. Epub 2012 Jul 25. 2012
46C9orf72
Clinical phenotypes and genetic biomarkers of FTLD.
Galimberti D, Scarpini E.
J Neural Transm 119(7):851-60. doi: 10.1007/s00702-012-0804-0. Epub 2012 Apr 19. Review. 2012
47C9orf72
Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
Millecamps S, Boillée S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, Moigneu C, Vandenberghe N, Danel-Brunaud V, Corcia P, Pradat PF, Le Forestier N, Lacomblez L, Bruneteau G, Camu W, Brice A, Cazeneuve C, Leguern E, Meininger V, Salachas F.
J Med Genet 49(4):258-63. doi: 10.1136/jmedgenet-2011-100699. 2012
48ALS8, ALSFTD1, C9orf72, VAPB
VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient.
van Blitterswijk M, van Es MA, Koppers M, van Rheenen W, Medic J, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH.
Neurobiol Aging 33(12):2950.e1-4. doi: 10.1016/j.neurobiolaging.2012.07.004. Epub 2012 Aug 9. 2012
49C9ORF72
Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis.
Herdewyn S, Zhao H, Moisse M, Race V, Matthijs G, Reumers J, Kusters B, Schelhaas HJ, van den Berg LH, Goris A, Robberecht W, Lambrechts D, Van Damme P.
Hum Mol Genet 21(11):2412-9. doi: 10.1093/hmg/dds055. Epub 2012 Feb 17. 2012
50C9orf72
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW.
Acta Neuropathol 122(6):673-90. doi: 10.1007/s00401-011-0907-y. Epub 2011 Nov 15. 2011
51C9orf72
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R.
Neuron 72(2):245-56. doi: 10.1016/j.neuron.2011.09.011. Epub 2011 Sep 21. 2011
52ACTL7A, ACTL7B, ANKRD18B, ANKRD20A2, ANKRD20A3, ANKRD20A4, ARRDC1, C9orf114, C9orf118, C9orf122, C9orf123, C9orf125, C9orf130, C9orf134, C9orf135, C9orf142, C9orf29, C9orf71, C9orf72, CBWD6, CBWD7, CNTLN, DCTN3, DMRT3, FAM189A2, FAM27D1, FAM27E1, FAM27E2, FAM74A1, FAM74A3, FAM74A4, FAM75A1, FGD3, FOXB2, FOXD4, FOXD4L5, GLT6D1, IARS, KIAA1045, KIAA2026, MED27, MEGF9, MOST2, PALM2, RABEPK, RFX3, SCAI, SMU1, ZCCHC7, ZDHHC12
DNA sequence and analysis of human chromosome 9.
Humphray SJ, Oliver K, Hunt AR, Plumb RW, Loveland JE, Howe KL, Andrews TD, Searle S, Hunt SE, Scott CE, Jones MC, Ainscough R, Almeida JP, Ambrose KD, Ashwell RI, Babbage AK, Babbage S, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beasley H, Beasley O, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burford D, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Chen Y, Clarke G, Clark SY, Clee CM, Clegg S, Collier RE, Corby N, Crosier M, Cummings AT, Davies J, Dhami P, Dunn M, Dutta I, Dyer LW, Earthrowl ME, Faulkner L, Fleming CJ, Frankish A, Frankland JA, French L, Fricker DG, Garner P, Garnett J, Ghori J, Gilbert JG, Glison C, Grafham DV, Gribble S, Griffiths C, Griffiths-Jones S, Grocock R, Guy J, Hall RE, Hammond S, Harley JL, Harrison ES, Hart EA, Heath PD, Henderson CD, Hopkins BL, Howard PJ, Howden PJ, Huckle E, Johnson C, Johnson D, Joy AA, Kay M, Keenan S, Kershaw JK, Kimberley AM, King A, Knights A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd C, Lloyd DM, Lovell J, Martin S, Mashreghi-Mohammadi M, Matthews L, McLaren S, McLay KE, McMurray A, Milne S, Nickerson T, Nisbett J, Nordsiek G, Pearce AV, Peck AI, Porter KM, Pandian R, Pelan S, Phillimore B, Povey S, Ramsey Y, Rand V, Scharfe M, Sehra HK, Shownkeen R, Sims SK, Skuce CD, Smith M, Steward CA, Swarbreck D, Sycamore N, Tester J, Thorpe A, Tracey A, Tromans A, Thomas DW, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Williams SA, Wilming L, Wray PW, Young L, Ashurst JL, Coulson A, Bl�cker H, Durbin R, Sulston JE, Hubbard T, Jackson MJ, Bentley DR, Beck S, Rogers J, Dunham I.
Nature 429(6990):369-74. 2004